188 related articles for article (PubMed ID: 10417772)
1. Heterogenous susceptibility to CD95-induced apoptosis in melanoma cells correlates with bcl-2 and bcl-x expression and is sensitive to modulation by interferon-gamma.
Ugurel S; Seiter S; Rappl G; Stark A; Tilgen W; Reinhold U
Int J Cancer; 1999 Aug; 82(5):727-36. PubMed ID: 10417772
[TBL] [Abstract][Full Text] [Related]
2. IL-4 protects tumor cells from anti-CD95 and chemotherapeutic agents via up-regulation of antiapoptotic proteins.
Conticello C; Pedini F; Zeuner A; Patti M; Zerilli M; Stassi G; Messina A; Peschle C; De Maria R
J Immunol; 2004 May; 172(9):5467-77. PubMed ID: 15100288
[TBL] [Abstract][Full Text] [Related]
3. Frequent downregulation of Fas (CD95) expression and function in melanoma.
Bullani RR; Wehrli P; Viard-Leveugle I; Rimoldi D; Cerottini JC; Saurat JH; Tschopp J; French LE
Melanoma Res; 2002 Jun; 12(3):263-70. PubMed ID: 12140383
[TBL] [Abstract][Full Text] [Related]
4. Expression of c-FLIP(L) and resistance to CD95-mediated apoptosis of monocyte-derived dendritic cells: inhibition by bisindolylmaleimide.
Willems F; Amraoui Z; Vanderheyde N; Verhasselt V; Aksoy E; Scaffidi C; Peter ME; Krammer PH; Goldman M
Blood; 2000 Jun; 95(11):3478-82. PubMed ID: 10828032
[TBL] [Abstract][Full Text] [Related]
5. Enhanced expression of Fas-associated death domain-like IL-1-converting enzyme (FLICE)-inhibitory protein induces resistance to Fas-mediated apoptosis in activated mast cells.
Yoshikawa H; Nakajima Y; Tasaka K
J Immunol; 2000 Dec; 165(11):6262-9. PubMed ID: 11086061
[TBL] [Abstract][Full Text] [Related]
6. Fas/APO-1 (CD95)-mediated apoptosis is activated by interferon-gamma and interferon- in interleukin-6 (IL-6)-dependent and IL-6-independent multiple myeloma cell lines.
Spets H; Georgii-Hemming P; Siljason J; Nilsson K; Jernberg-Wiklund H
Blood; 1998 Oct; 92(8):2914-23. PubMed ID: 9763578
[TBL] [Abstract][Full Text] [Related]
7. Constitutive caspase activation and impaired death-inducing signaling complex formation in CD95-resistant, long-term activated, antigen-specific T cells.
Strauss G; Knape I; Melzner I; Debatin KM
J Immunol; 2003 Aug; 171(3):1172-82. PubMed ID: 12874203
[TBL] [Abstract][Full Text] [Related]
8. Interferon-gamma augments CD95(APO-1/Fas) and pro-caspase-8 expression and sensitizes human vascular endothelial cells to CD95-mediated apoptosis.
Li JH; Kluger MS; Madge LA; Zheng L; Bothwell AL; Pober JS
Am J Pathol; 2002 Oct; 161(4):1485-95. PubMed ID: 12368221
[TBL] [Abstract][Full Text] [Related]
9. The Bax/Bcl-2 ratio determines the susceptibility of human melanoma cells to CD95/Fas-mediated apoptosis.
Raisova M; Hossini AM; Eberle J; Riebeling C; Wieder T; Sturm I; Daniel PT; Orfanos CE; Geilen CC
J Invest Dermatol; 2001 Aug; 117(2):333-40. PubMed ID: 11511312
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2, Bcl-xL and c-FLIP(L) potentially regulate the susceptibility of human peripheral blood monocyte-derived dendritic cells to cell death at different developmental stages.
Hasebe H; Sato K; Yanagie H; Takeda Y; Nonaka Y; Takahashi TA; Eriguchi M; Nagawa H
Biomed Pharmacother; 2002 May; 56(3):144-51. PubMed ID: 12046686
[TBL] [Abstract][Full Text] [Related]
11. Metabolic inhibitors sensitize for CD95 (APO-1/Fas)-induced apoptosis by down-regulating Fas-associated death domain-like interleukin 1-converting enzyme inhibitory protein expression.
Fulda S; Meyer E; Debatin KM
Cancer Res; 2000 Jul; 60(14):3947-56. PubMed ID: 10919673
[TBL] [Abstract][Full Text] [Related]
12. Resistance of short term activated T cells to CD95-mediated apoptosis correlates with de novo protein synthesis of c-FLIPshort.
Schmitz I; Weyd H; Krueger A; Baumann S; Fas SC; Krammer PH; Kirchhoff S
J Immunol; 2004 Feb; 172(4):2194-200. PubMed ID: 14764686
[TBL] [Abstract][Full Text] [Related]
13. Mature dendritic cells are protected from Fas/CD95-mediated apoptosis by upregulation of Bcl-X(L).
Lundqvist A; Nagata T; Kiessling R; Pisa P
Cancer Immunol Immunother; 2002 May; 51(3):139-44. PubMed ID: 11941452
[TBL] [Abstract][Full Text] [Related]
14. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
[TBL] [Abstract][Full Text] [Related]
15. TNF-alpha and IFN-gamma render microglia sensitive to Fas ligand-induced apoptosis by induction of Fas expression and down-regulation of Bcl-2 and Bcl-xL.
Spanaus KS; Schlapbach R; Fontana A
Eur J Immunol; 1998 Dec; 28(12):4398-408. PubMed ID: 9862377
[TBL] [Abstract][Full Text] [Related]
16. Adhesion-mediated intracellular redistribution of c-Fas-associated death domain-like IL-1-converting enzyme-like inhibitory protein-long confers resistance to CD95-induced apoptosis in hematopoietic cancer cell lines.
Shain KH; Landowski TH; Dalton WS
J Immunol; 2002 Mar; 168(5):2544-53. PubMed ID: 11859150
[TBL] [Abstract][Full Text] [Related]
17. Interferon-gamma and anti-Fas antibody-induced apoptosis in human melanoma cell lines and its relationship to bcl-2 cleavage and bak expression.
Kamei T; Inui M; Nakamura S; Okumura K; Goto A; Tagawa T
Melanoma Res; 2003 Apr; 13(2):153-9. PubMed ID: 12690298
[TBL] [Abstract][Full Text] [Related]
18. Expression of Apo-1/Fas (CD95), Bcl-2, Bax and Bcl-x in myeloma cell lines: relationship between responsiveness to anti-Fas mab and p53 functional status.
Egle A; Villunger A; Marschitz I; Kos M; Hittmair A; Lukas P; Grünewald K; Greil R
Br J Haematol; 1997 May; 97(2):418-28. PubMed ID: 9163609
[TBL] [Abstract][Full Text] [Related]
19. Up-regulation of c-FLIPshort and reduction of activation-induced cell death in CD28-costimulated human T cells.
Kirchhoff S; Müller WW; Li-Weber M; Krammer PH
Eur J Immunol; 2000 Oct; 30(10):2765-74. PubMed ID: 11069056
[TBL] [Abstract][Full Text] [Related]
20. Nitric oxide-mediated apoptosis in human breast cancer cells requires changes in mitochondrial functions and is independent of CD95 (APO-1/Fas).
Umansky V; Ushmorov A; Ratter F; Chlichlia K; Bucur M; Lichtenauer A; Rocha M
Int J Oncol; 2000 Jan; 16(1):109-17. PubMed ID: 10601555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]